» Articles » PMID: 36061855

COVID-19 Perceived Stigma Among Survivors: A Cross-sectional Study of Prevalence and Predictors

Overview
Date 2022 Sep 5
PMID 36061855
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: Perceived stigma related to infectious diseases is of public health importance and can adversely impact patients' physical and mental health. This study aims to identify the level of perceived stigma among COVID-19 survivors in Qatar and investigate its predictors.

Methods: An analytical cross-sectional design was employed. Four hundred and four participants who had a positive COVID-19 PCR test were randomly selected from medical records. The selected participants were interviewed to collect sociodemographic and health-related information. Perceived stigma was assessed using the COVID-19 perceived stigma scale-22 (CPSS-22) that was developed by the researchers. A descriptive analysis followed by a bivariate analysis investigated possible associations between the perceived stigma levels and independent variables. A multivariable analysis was performed using logistic regression to identify any significant associations with perceived stigma. The validity and reliability of the developed tool were also tested.

Results: The prevalence of COVID-19 perceived stigma was twenty-six percent ( = 107, 26.4%) at 95% CI [22.4-30.4]. Factors associated with higher COVID-19 perceived stigma were male gender, being a manual worker, non-Arabic ethnicity, low educational level, living alone, and being isolated outside the home. However, only occupation, ethnicity, and low educational level predicted COVID-19 perceived stigma in multivariable analysis. The CPSS-22 showed excellent reliability (Cronbach's alpha 0.92).

Conclusion: Perceived stigma was relatively common among participants. Designing programs and interventions targeting male manual workers and those of low-educational levels may assist policymakers in mitigating the stigma related to COVID-19.

Citing Articles

Stigma in Pediatric Cancer: An Exploratory Study of Osteosarcoma and Retinoblastoma in Guatemala, Jordan, and Zimbabwe.

Graetz D, Velasquez T, Chitsike I, Halalsheh H, Caceres-Serrano A, Fuentes L JCO Glob Oncol. 2024; 10:e2400017.

PMID: 38905576 PMC: 11191872. DOI: 10.1200/GO.24.00017.


Unraveling socioeconomic determinants of health-related behavior, reception of information, and perceptions on disease disclosure at the time of the COVID-19 pandemic: did health insurance curb the disparities in the Philippines?.

Estrada J BMC Public Health. 2024; 24(1):767.

PMID: 38475807 PMC: 10935915. DOI: 10.1186/s12889-024-18264-9.


Systematic Review of Scales for Measuring Infectious Disease-Related Stigma.

Paterson A, Cheyne A, Jones B, Schilling S, Sigfrid L, Stolow J Emerg Infect Dis. 2024; 30(3):519-529.

PMID: 38407230 PMC: 10902531. DOI: 10.3201/eid3003.230934.


Social stigma during COVID-19: A systematic review.

SeyedAlinaghi S, Afsahi A, Shahidi R, Afzalian A, Mirzapour P, Eslami M SAGE Open Med. 2023; 11:20503121231208273.

PMID: 38020797 PMC: 10640804. DOI: 10.1177/20503121231208273.


Prevalence and predictors of perceived COVID-19 stigma within a population-based sample of adults with COVID-19.

Ryu S, Chaubal S, Guro P, King E, Orellana R, Fleischer N BMC Public Health. 2023; 23(1):2110.

PMID: 37891499 PMC: 10604399. DOI: 10.1186/s12889-023-17042-3.


References
1.
Cataldo J, Slaughter R, Jahan T, Pongquan V, Hwang W . Measuring stigma in people with lung cancer: psychometric testing of the cataldo lung cancer stigma scale. Oncol Nurs Forum. 2010; 38(1):E46-54. PMC: 3182474. DOI: 10.1188/11.ONF.E46-E54. View

2.
OConnell A, Reed S, Serovich J . The efficacy of serostatus disclosure for HIV Transmission risk reduction. AIDS Behav. 2014; 19(2):283-90. PMC: 4435532. DOI: 10.1007/s10461-014-0848-2. View

3.
Muhidin S, Vizheh M, Behboodi Moghadam Z . Anticipating COVID-19-related stigma in survivors and health-care workers: Lessons from previous infectious diseases outbreaks - An integrative literature review. Psychiatry Clin Neurosci. 2020; 74(11):617-618. DOI: 10.1111/pcn.13140. View

4.
Person B, Sy F, Holton K, Govert B, Liang A . Fear and stigma: the epidemic within the SARS outbreak. Emerg Infect Dis. 2004; 10(2):358-63. PMC: 3322940. DOI: 10.3201/eid1002.030750. View

5.
Lohiniva A, Dub T, Hagberg L, Nohynek H . Learning about COVID-19-related stigma, quarantine and isolation experiences in Finland. PLoS One. 2021; 16(4):e0247962. PMC: 8046198. DOI: 10.1371/journal.pone.0247962. View